Ivabradine successfully reduced the mean heart rate from 171 to 139 beats per minute in a neonate with refractory ectopic atrial tachycardia, without causing haemodynamic compromise.
Case Report (n=1)
No
Does ivabradine reduce heart rate in neonates with refractory ectopic atrial tachycardia?
Ivabradine may be a viable therapeutic option for neonatal ectopic atrial tachycardia when standard treatments fail.
Absolute Event Rate: 139% vs 171%
Neonatal ectopic atrial tachycardia is a rare arrhythmia that may be resistant to conventional therapy. We report a neonate with persistent foetal tachycardia refractory to flecainide and digoxin. Ivabradine resulted in rapid and sustained heart rate reduction without haemodynamic compromise. This case supports ivabradine as a therapeutic option in neonatal automatic tachycardias when standard treatments fail.
Adell et al. (Fri,) conducted a case report in Refractory neonatal ectopic atrial tachycardia (n=1). Ivabradine vs. Flecainide and digoxin (prior therapy) was evaluated on Mean heart rate (beats per minute). Ivabradine successfully reduced the mean heart rate from 171 to 139 beats per minute in a neonate with refractory ectopic atrial tachycardia, without causing haemodynamic compromise.